These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 30910327)
1. Prevention of decompensation in cirrhosis: a new youth for β blockers. Levy S; Samuel D Lancet; 2019 Apr; 393(10181):1571-1572. PubMed ID: 30910327 [No Abstract] [Full Text] [Related]
2. In compensated cirrhosis with portal hypertension, β-blockers reduced a composite of decompensation or death. Korula J Ann Intern Med; 2019 Aug; 171(4):JC21. PubMed ID: 31426064 [No Abstract] [Full Text] [Related]
3. Development of hyperdynamic circulation and response to β-blockers in compensated cirrhosis with portal hypertension. Villanueva C; Albillos A; Genescà J; Abraldes JG; Calleja JL; Aracil C; Bañares R; Morillas R; Poca M; Peñas B; Augustin S; Garcia-Pagan JC; Pavel O; Bosch J Hepatology; 2016 Jan; 63(1):197-206. PubMed ID: 26422126 [TBL] [Abstract][Full Text] [Related]
5. Editorial: Beta-blockers and the prevention of decompensation in cirrhosis: worth the trouble. Northup PG; Henry ZH Am J Gastroenterol; 2012 Mar; 107(3):428-30. PubMed ID: 22388023 [TBL] [Abstract][Full Text] [Related]
6. Effects of Sapropterin on Portal and Systemic Hemodynamics in Patients With Cirrhosis and Portal Hypertension: A Bicentric Double-Blind Placebo-Controlled Study. Reverter E; Mesonero F; Seijo S; Martínez J; Abraldes JG; Peñas B; Berzigotti A; Deulofeu R; Bosch J; Albillos A; García-Pagán JC Am J Gastroenterol; 2015 Jul; 110(7):985-92. PubMed ID: 26077176 [TBL] [Abstract][Full Text] [Related]
7. [Not Available]. Kleefisch M; Lange C; Wedemeyer H MMW Fortschr Med; 2019 Nov; 161(20):39. PubMed ID: 31773605 [No Abstract] [Full Text] [Related]
8. Development of ascites in compensated cirrhosis with severe portal hypertension treated with β-blockers. Hernández-Gea V; Aracil C; Colomo A; Garupera I; Poca M; Torras X; Miñana J; Guarner C; Villanueva C Am J Gastroenterol; 2012 Mar; 107(3):418-27. PubMed ID: 22334252 [TBL] [Abstract][Full Text] [Related]
9. [Long-term drug treatments to improve prognosis of patients with liver cirrhosis and to prevent complications due to portal hypertension]. Holstege A Z Gastroenterol; 2019 Aug; 57(8):983-996. PubMed ID: 31398770 [TBL] [Abstract][Full Text] [Related]
10. Editorial: Beta blockers and cirrhosis-more than just portal hypertension? Ttl Tjwa E Aliment Pharmacol Ther; 2021 Mar; 53(5):644-645. PubMed ID: 33566416 [No Abstract] [Full Text] [Related]